[JANX] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 19.82%
YoY- 16.07%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 2,461 2,845 1,616 0 -
PBT -11,758 -16,065 -13,416 -1,655 92.24%
Tax 953 -4,805 -74 0 -
NP -11,758 -11,260 -13,416 -1,655 92.24%
Tax Rate - - - - -
Total Cost 14,219 14,105 15,032 1,655 104.81%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -477.77 -395.78 -830.20 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.25 -0.27 -0.33 -0.13 24.35%
EPS Diluted -0.25 -0.27 -0.33 -0.13 24.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.